23%; P Â¼ .02),
although this difference was due to a higher incidence

of DVT in patients undergoing sclerotherapy
(Table XXII). Although total VTE events were higher
among patients undergoing RFA in comparison with
EVLA (3.1% vs 2.2%; P < .001), EHIT was higher in patients
undergoing EVLA (4.4% vs 3.0%; P < .001).